Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0006142 (
breast cancer
)
160,383
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A measurement technique has been developed for application in the area of noninvasive
breast cancer
detection. The measurement process involves the use of close-range stereophotogrammetry as a data acquisition device necessary for determination of breast volume and volume distribution. This report details the methodology used to acquire and analyze stereopair photographs necessary to document the validity and reliability of this application. The volume of a test object was determined by both
water
displacement and stereophotogrammetric analysis to estimate the precision of the proposed methodology. Additionally, the reliability component of the study was documented by analyzing variability of coordinates representing a series of locations marked on the surface of an irregularly shaped object. Both tests confirm that this stereometric analysis is a reliable and valid method of measurement and may be well suited for further development in the field of
breast cancer
detection.
...
PMID:Validity and reliability of biostereometric measurement of the human female breast. 370 52
Between March 1980 and April 1981, 1,140 women underwent physical examination, xeromammography, and whole-breast ultrasound (US) using a whole-breast
water
path system. Results of each study were interpreted independently by separate observers in a blind fashion. Biopsy revealed 125 cancers in 127 breasts. Findings were considered to be suspicious for carcinoma in 199 women based on physical examination, in 201 based on mammograms, and in 255 based on US scans. Physical examinations were able to reveal 91% (115/127) of the cancers, reflecting the referral nature of the population, and failed to detect 12 lesions. Mammograms disclosed 94% (119/127) of the cancers, including 12 clinically occult lesions, but did not show eight palpable cancers. US scans disclosed only 64% (81/127) of the cancers, all of which were palpable. In a 4-year follow-up, no cancers have appeared in the group that had suspicious findings by US only. We conclude that US should not be used routinely to screen women for
breast cancer
.
...
PMID:Whole-breast US imaging: four-year follow-up. 390 Nov 12
The effects of cytotoxic therapy on the structure and function of the proximal jejunum were studied in six patients receiving intravenous cyclophosphamide (300 mg/m2), methotrexate (40 mg/m2), and 5-fluorouracil (600 mg/m2) as adjuvant therapy for
breast cancer
. Using a steady state, triple lumen tube perfusion system the absorption of
water
and electrolytes was measured before and 48 h after administration of the cytotoxic agents. Jejunal biopsies were obtained at each perfusion. Median (range)
water
absorption fell from 126 (40-142) to 84 (46-142) ml/h/30 cm, with parallel changes for electrolytes; none of the changes was significant. Brush border disaccharidases did not change at 48 h after chemotherapy, while mature enterocytes appeared normal by both light and electron microscopy. Crypt cells and immature enterocytes, however, showed focal vacuolation by light microscopy, corresponding to the occurrence of large residual bodies (secondary lysosomes) containing partially degraded fragments of damaged crypt cells. The confinement of ultrastructural changes to the immature cell population may explain the failure of this study to show a consistent change in the absorptive function of the jejunum 48 h after chemotherapy.
...
PMID:Functional and structural changes of the human proximal small intestine after cytotoxic therapy. 391 64
The synthetic non-steroidal antioestrogen nafoxidine (U-11, 100A) was given by mouth to 52 women with locally advanced or metastatic breast cancer, in 85% of whom the disease had become resistant to, or relapsed after, previous endocrine treatment. The objective response rate (complete or partial regression of disease) among 48 cases treated for at least four weeks was 37%. Tumours in soft tissue seemed to respond better than skeletal metastases. The patients in all but one of the 52 cases were postmenopausal. Those who had had an objective response to previous hormone treatment had a greater chance of deriving benefit from nafoxidine than those who had been resistant to hormone treatment.Side effects of nafoxidine were dryness of skin, increased loss of scalp hair, and heightened sensitivity to sunlight. None were serious, and they could be lessened by protection from solar radiation or a decrease in dosage. No obvious depression of thyroid or adrenal function or obvious
water
retention or masculinization was seen. Cataract was a possible complication.This clinical trial was preceded by laboratory studies in which a transplantable oestrogen-dependent tumour in the Syrian hamster was notably inhibited by the administration of nafoxidine. This experimental model may prove useful in screening potentially useful antioestrogenic agents against
breast cancer
before a human trial.
...
PMID:Antioestrogens in treatment of breast cancer: value of nafoxidine in 52 advanced cases. 436 55
The female breast can be easily examined by sonography due to its anatomical site. Today
water
-coupling methods or real-time scanners with high transducer frequency are the procedures of choice. The sonographic picture of the normal breast is described and a discussion presented of the criteria on which the differential diagnosis between cystic and solid lesions is based. The domain of sonography is the demonstration of cystic lesions as from a diameter of 3 mm. Solid lesions must be bigger to become demonstrable by sonography. Sonography is at present incapable of replacing mammography as a screening method for the early detection of
breast cancer
for several reasons. Primarily one has to spend at least half an hour for an exact examination of both breasts. A more serious disadvantage, however, is the fact that the majority of breast cancers demonstrated by sonography is far beyond the early stages. It was, moreover, observed that the sonographic appearance of the tumour was dependent on the cellular content of the tumour as well as the connective tissue density. Tumours with a high cellular content are more easily penetrable by ultrasonic waves and might, therefore, be misinterpreted as being a benign lesion. On comparing mammography and sonography it is interesting to note that tumours in a dense breast are more easily detectable by sonography, whilst tumours in a breast rich in fatty tissue are more easily demonstrated by mammography.
...
PMID:[Diagnostic sonography of the female breast]. 631 58
The results of nonspecific immunotherapy with BCG vaccine in 98 cases of melanoma,
breast cancer
and other malignancies were used in evaluating the frequency and degree of side-effects and complications arising in cancer patients during this treatment. The procedure proved to be safe irrespective of patients' age. Prevention and treatment of side-effects such as fever,
water
-salt disorders, anorexia, interstitial hepatitis and promotion of tumor growth are discussed.
...
PMID:[Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms]. 646 96
In an attempt to identify the factors which might affect the measurement of
water
proton relaxation times in cultured cells, we have begun a long-term study of two human
breast cancer
cell lines, MDA-MB-231 and MDA-MB-435s. We tested growth rates and cell cycle distribution as intrinsic properties of the cells as well as methodological steps which might affect the measurement of T1 and T2. A detailed examination of the growth rates of the two cell lines, easily recognized as slow (231) and fast (435s) in culture, revealed that this attribute is difficult to correlate precisely with T1s or T2s. The reason is that the relaxation times are necessarily measured at one point in time while the growth rates are a summation of ongoing processes occurring over hours. Cell cycle distribution, on the other hand, can be measured simultaneously with the relaxation times by using cells quick-frozen from the same suspension. By this method, cell cycle distribution appears to be reflected through an effect on T1s. For example, cell pellets distributed 72:15:14 in G0G1:S:G2M has longer T1s (p less than 0.01) than those distributed 43:34:23 in G0G1:S:G2M. Regarding methodological factors, trypsin appeared to lower
water
content and T2s in the 231 cell line. Drift in the cell cycle distribution after sample preparation did not become significant until after 2 hours in the NMR tube. It was important to standardize the force and duration of centrifugation of the cell pellets to minimize the contribution of the suspending medium without affecting cell viability. We conclude that, given careful control of methodological factors, differences in T1 may reflect metabolic differences as demonstrated by T1 differences in cell pellets showing divergent cell cycle distribution.
...
PMID:Methodological aspects of analysing human breast cancer cell lines by NMR spectroscopy. 653 2
This prospective study, involving 1,000 women referred for routine mammography, compares the
breast cancer
detecting abilities of state-of-the-art mammography and sonography using an automated
water
-path scanner. Mammography was found to be the superior technique, detecting 62 (97%) of the 64 pathologically proven cancers, while sonography detected only 37 (58%). When considering those cancers most amenable to cure, mammography detected over 90% in all categories, but sonography detected only 48% of the cancers that had not yet spread to axillary lymph nodes, only 30% of the nonpalpable malignancies, and only 8% of the cancers smaller than 1 cm. These data indicate that sonography is not an acceptable substitute for mammography in the detection and diagnosis of
breast cancer
. The data further suggest that radiologists who wish to improve the cancer-detecting ability of their current breast imaging operation should upgrade their mammography to state-of-the-art status before adding an automated whole-breast ultrasound scanner.
...
PMID:Breast cancer detection with sonography and mammography: comparison using state-of-the-art equipment. 660 22
The oestradiol (RE) and progesterone (RP) receptor levels were analyzed in 26 tumour fragments (200-500 mg) from
breast cancer
patients. After pulverization of tissue, one part was analyzed by the routine dextran-coated charcoal (DCC) method and the other by a micromethod as follows: (i) cytosol incubation using the DCC method but in the simultaneous presence of [3H]oestradiol and [3H]R5020 (ii) extraction of the steroids bound to the receptor by precipitation with ethanol/TCA (iii) high pressure liquid chromatography (HPLC) on a modular system, with a C185 microns column and an elution by gradient mixture methanol/
water
. The fractions were collected and the radioactivity counted. The separation of oestradiol from R 5020 was rapid and complete. In addition dexamethasone was separated by this system making possible triple measures of RE, RP and glucocorticoid receptors. A highly significant correlation was obtained between the 2 methods: RE = 0.996, P less than 0.001; RP r = 0.975, P less than 0.001, implying that the thresholds of positivity, i.e. for therapeutic decisions, remain unchanged. Simultaneous measurement of RE and RP in a single needle biopsy is possible with this micromethod.
...
PMID:Simultaneous micro measurement of steroid receptors in breast cancer. 662 56
Human breast carcinomas contain aromatase, the enzyme necessary for the conversion of androgens to estrogens. If present in sufficient amounts, aromatase could catalyze the synthesis of estrogens from plasma steroid precursors and produce high
breast cancer
tissue concentrations. To determine the biological importance of tumor aromatase, we validated a specific and highly sensitive 3H-labeled
water
release assay for aromatase and used this to quantitate the amount of estrogen synthesized in vitro in breast tumors. As proof of assay validity, the [3H]
water
release assay detected 22.7 +/- 0.09 (+/- SEM) pmol/g . h estrogen formed vs. 24.7 pmol/g . h with the direct product isolation assay. Of 61 human breast tumors studied, 48 contained measurable aromatase activity, ranging from 5-70.5 pmol estrone formed/g . h. Three aromatase inhibitors (aminoglutethimide, testololactone, and 4-hydroxyandrostenedione) blocked this activity at concentrations similar to those affecting aromatase activity in other tissues. If biologically important, the estrogen formed locally from aromatase would be expected to stimulate production of the progesterone receptor. Under these circumstances, a positive correlation of progesterone receptor and local estrogen production should be found. In contrast, no significant correlation between aromatase activity and progesterone receptor level was observed (r = -0.27; P = NS). In addition, no correlation between estrogen receptor content and aromatase activity was detected. Finally, the amount of aromatase activity present in most tumors was insufficient to produce biologically meaningful saturation of estrogen receptors. These observations suggested that aromatase, while present in the majority of
breast cancer
tissues, may only be biologically important in those few tumors with very high aromatase activity.
...
PMID:Biological significance of aromatase activity in human breast tumors. 663 Apr 10
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>